Australia offers a wealth
of opportunities

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font

Investor Update: BiotechnologyClick to subscribe to this Investor Updates RSS feed

GSK invests in Australian healthcare innovation
10 Feb 2012
Global pharmaceutical company, GlaxoSmithKlein (GSK), will invest A$60 million to enhance its manufacturing capability and Research & Development activities in Australia.
Australia’s largest biologics site destined for Brisbane
15 Dec 2011
Brisbane will house a major biopharmaceutical manufacturing site with a new collaboration announced between the Queensland Government, The University of Queensland and DSM Biologics.
Australia at the cutting edge of stem cell research
18 Nov 2011
A new stem cell research centre launched in Melbourne last week will allow Australian scientists to pioneer new approaches in the treatment of major health problems.
Australian pharma attracts Swiss investment
3 Nov 2011
Global pharmaceutical companies Lonza Group and Mesoblast Limited have entered into a strategic alliance to produce regenerative off-the-shelf adult stem cell products.
Brain research centre opens in Melbourne
21 Oct 2011
Australia is now home to the world’s fifth largest brain research facility with the opening of a A$225 million centre in Melbourne this month.
Investment syndicate boosts Australian biotech commercialisation
11 Aug 2011
A new consortium of local and foreign investors will enable an Australian biotech venture, Vaxxas, to commercialise its unique product.
New bionic hearing aid developed in Australia
18 May 2011
Researchers based in Melbourne, Australia have invented a smart, self-managed hearing aid using bionic ear technology.
Australia continues to be an attractive destination for FDI
6 May 2011
Foreign direct investment (FDI) into Australia continues to grow, demonstrating investor confidence in the strong Australian economy. Data released by the Australian Bureau of Statistics* shows that, year on year, FDI into Australia grew by 7.5 per c ...
Cutting-edge cancer centre to open in Australia
17 Dec 2010
German company Fresenius Kabi will open a $3.5 million oncology compounding centre in Brisbane, in the New Year.
Construction begins on Australia’s first Translational Research Institute
3 Dec 2010
Construction has begun on Australia’s first Translational Research Institute (TRI): a facility dedicated to translating scientific discoveries into applications for medical practice.

Site Information

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.